News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
385,000 Results
Type
Article (23944)
Company Profile (41)
Press Release (361013)
Multimedia
Podcasts (125)
Webinars (14)
Section
Business (119766)
Career Advice (1434)
Deals (17514)
Drug Delivery (73)
Drug Development (42706)
Employer Resources (97)
FDA (9060)
Job Trends (8467)
News (191824)
Policy (17352)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (1521)
Academic (1)
Accelerated approval (23)
Adcomms (15)
Allergies (106)
Alliances (33425)
ALS (126)
Alzheimer's disease (1027)
Antibody-drug conjugate (ADC) (236)
Approvals (9357)
Artificial intelligence (411)
Autoimmune disease (156)
Automation (36)
Bankruptcy (156)
Best Places to Work (7027)
BIOSECURE Act (7)
Biosimilars (122)
Biotechnology (37)
Bladder cancer (123)
Brain cancer (35)
Breast cancer (445)
Cancer (3519)
Cardiovascular disease (314)
Career advice (1241)
Career pathing (33)
CAR-T (157)
CDC (28)
Cell therapy (502)
Cervical cancer (27)
Clinical research (37433)
Collaboration (1443)
Company closure (2)
Compensation (319)
Complete response letters (32)
COVID-19 (1529)
CRISPR (67)
C-suite (524)
Cystic fibrosis (85)
Data (4942)
Decentralized trials (3)
Denatured (42)
Depression (96)
Dermatology (39)
Diabetes (406)
Diagnostics (3703)
Digital health (30)
Diversity (7)
Diversity, equity & inclusion (29)
Drug discovery (197)
Drug pricing (105)
Drug shortages (22)
Duchenne muscular dystrophy (175)
Earnings (59007)
Editorial (45)
Employer branding (12)
Employer resources (84)
Events (58392)
Executive appointments (570)
FDA (11336)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (9)
Frontotemporal dementia (23)
Funding (929)
Gene editing (137)
Generative AI (45)
Gene therapy (459)
GLP-1 (651)
Government (2440)
Grass and pollen (6)
Guidances (334)
Healthcare (10255)
HIV (55)
Huntington's disease (34)
IgA nephropathy (67)
Immunology and inflammation (161)
Immuno-oncology (57)
Indications (122)
Infectious disease (1705)
Inflammatory bowel disease (134)
Inflation Reduction Act (12)
Influenza (73)
Intellectual property (167)
Interviews (272)
IPO (8433)
IRA (30)
Job creations (1752)
Job search strategy (998)
JPM (46)
Kidney cancer (10)
Labor market (54)
Layoffs (263)
Leadership (32)
Legal (4434)
Liver cancer (50)
Longevity (16)
Lung cancer (480)
Lymphoma (289)
Machine learning (32)
Management (33)
Manufacturing (587)
MASH (130)
Medical device (7178)
Medtech (7224)
Mergers & acquisitions (9828)
Metabolic disorders (970)
mRNA (107)
Multiple sclerosis (121)
NASH (9)
Neurodegenerative disease (234)
Neuropsychiatric disorders (55)
Neuroscience (1901)
NextGen: Class of 2026 (3432)
Non-profit (2716)
Now hiring (11)
Obesity (421)
Opinion (207)
Ovarian cancer (103)
Pain (134)
Pancreatic cancer (157)
Parkinson's disease (210)
Partnered (24)
Patents (324)
Patient recruitment (322)
Peanut (33)
People (28347)
Pharmaceutical (9)
Pharmacy benefit managers (16)
Phase 1 (11197)
Phase 2 (15937)
Phase 3 (13351)
Pipeline (5305)
Policy (175)
Postmarket research (1670)
Preclinical (4885)
Press Release (31)
Prostate cancer (233)
Psychedelics (30)
Radiopharmaceuticals (183)
Rare diseases (652)
Real estate (2617)
Recruiting (38)
Regulatory (13438)
Reports (25)
Research institute (1377)
Resumes & cover letters (219)
Rett syndrome (21)
RNA editing (11)
RSV (50)
Schizophrenia (106)
Series A (168)
Series B (102)
Service/supplier (3)
Sickle cell disease (75)
Special edition (14)
Spinal muscular atrophy (80)
Sponsored (29)
Startups (1538)
State (1)
Stomach cancer (11)
Supply chain (65)
Tariffs (54)
The Weekly (82)
Vaccines (633)
Venture capital (54)
Weight loss (259)
Women's health (61)
Worklife (15)
Date
Today (62)
Last 7 days (469)
Last 30 days (1888)
Last 365 days (19214)
2026 (5136)
2025 (19146)
2024 (20371)
2023 (22385)
2022 (28437)
2021 (30182)
2020 (29496)
2019 (25368)
2018 (18804)
2017 (17820)
2016 (17336)
2015 (19837)
2014 (16558)
2013 (14501)
2012 (14376)
2011 (13857)
2010 (13017)
Location
Africa (552)
Alabama (64)
Alaska (4)
Arizona (146)
Arkansas (8)
Asia (22409)
Australia (3690)
California (7307)
Canada (2144)
China (747)
Colorado (344)
Connecticut (371)
Delaware (226)
Europe (53673)
Florida (1201)
Georgia (251)
Hawaii (1)
Idaho (24)
Illinois (570)
India (58)
Indiana (403)
Iowa (10)
Japan (333)
Kansas (77)
Kentucky (18)
Louisiana (14)
Maine (32)
Maryland (910)
Massachusetts (5282)
Michigan (220)
Minnesota (329)
Mississippi (2)
Missouri (61)
Montana (11)
Nebraska (9)
Nevada (86)
New Hampshire (39)
New Jersey (2329)
New Mexico (13)
New York (2041)
North Carolina (980)
North Dakota (5)
Northern California (3552)
Ohio (186)
Oklahoma (16)
Oregon (19)
Pennsylvania (1572)
Puerto Rico (7)
Rhode Island (26)
South America (759)
South Carolina (32)
Southern California (2995)
Tennessee (140)
Texas (1154)
United States (26624)
Utah (242)
Vermont (1)
Virginia (166)
Washington D.C. (52)
Washington State (589)
West Virginia (2)
Wisconsin (64)
Wyoming (2)
385,000 Results for "pump and brush finland oy".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
China
Lilly Pumps $3B Into China To Boost Supply of Weight Loss Pill
Orforglipron, Eli Lilly’s oral obesity drug, is under FDA review with a decision expected in April. The pharma has also filed for marketing authorization for the pill in China.
March 11, 2026
·
2 min read
·
Tristan Manalac
Press Releases
KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility
March 13, 2026
·
3 min read
Press Releases
Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo® in France, Denmark, Iceland, Sweden, Finland and Norway
January 8, 2026
·
5 min read
Press Releases
Portal Diabetes Gets FDA Breakthrough for Pump, Starts Insulin Study
February 17, 2026
·
2 min read
Press Releases
MiniMed Announces FDA Clearance of MiniMed Flex™, the Company’s Smallest Insulin Pump Featuring Its First Smartphone-Controlled Design
March 18, 2026
·
6 min read
Press Releases
Oncotelic Therapeutics and Brush and Key Foundation Announce Publication in International Journal of Molecular Sciences Highlighting Context-Dependent Biomarkers in Liver and Pancreatic Cancer
December 16, 2025
·
10 min read
Press Releases
OYE Therapeutics Raises $5.475 Million in a Series A to Advance Clinical Development of High-Concentration Caffeine Therapy for its Anesthesia Recovery and Drug Overdose Reversal
December 16, 2025
·
2 min read
Press Releases
Modular Medical Achieves Key Manufacturing Milestone for Pivot Tubeless Insulin Patch Pump
February 5, 2026
·
4 min read
Press Releases
CMS Maintains NOPAIN Act Eligibility for ON‑Q* and AmbIT* Infusion Pumps; Adds Game Ready* in 2026
February 3, 2026
·
4 min read
Funding
Novo Foundation Pumps $850M Into Denmark, Europe to Bolster Innovation
The Novo Nordisk Foundation’s funds will go toward supporting early-stage companies working in “human health, planetary health and societal resilience.”
January 16, 2026
·
2 min read
·
Tristan Manalac
1 of 38,500
Next
